Novartis AG

Historical 13F Holders

Symbol
NVS
CUSIP
66987V109
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 66987V109 since 12/18/2024, largest first.

Filer % of Class Filed
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 13G 6.4% 7/17/2025
Event 9/30/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1,040 50.1 M $7.14B
2026 Q2 1,645 136 M $21.3B
2026 Q1 1,620 144 M $22.0B
2025 Q4 1,530 134 M $18.4B
2025 Q3 1,416 134 M $17.2B
2025 Q2 1,400 134 M $16.2B
2025 Q1 1,370 139 M $15.4B
2024 Q4 1,353 131 M $12.7B
2024 Q3 1,324 132 M $15.2B
2024 Q2 1,319 138 M $14.7B
2024 Q1 1,264 140 M $13.6B
2023 Q4 1,285 141 M $14.2B
2023 Q3 1,235 149 M $15.1B
2023 Q2 1,212 149 M $14.9B
2023 Q1 1,192 172 M $15.2B
2022 Q4 1,195 171 M $15.9B
2022 Q3 1,098 183 M $13.9B
2022 Q2 1,149 200 M $16.9B
2022 Q1 1,145 208 M $18.3B
2021 Q4 1,156 211 M $18.5B
2021 Q3 1,089 220 M $18.0B
2021 Q2 1,129 217 M $19.8B
2021 Q1 1,142 219 M $18.7B
2020 Q4 1,185 228 M $21.9B
2020 Q3 1,129 226 M $19.7B
2020 Q2 1,138 238 M $20.7B
2020 Q1 1,141 248 M $20.4B
2019 Q4 1,179 258 M $24.4B
2019 Q3 1,099 244 M $21.3B
2019 Q2 1,105 257 M $23.5B
2019 Q1 1,142 274 M $26.2B
2018 Q4 1,093 273 M $23.4B
2018 Q3 1,034 261 M $22.5B
2018 Q2 990 257 M $19.4B
2018 Q1 1,017 256 M $20.7B
2017 Q4 1,016 251 M $21.1B
2017 Q3 945 259 M $22.2B
2017 Q2 930 260 M $21.7B
2017 Q1 914 268 M $19.9B
2016 Q4 913 251 M $18.3B
2016 Q3 879 236 M $18.7B
2016 Q2 883 235 M $19.5B
2016 Q1 876 238 M $17.3B
2015 Q4 925 234 M $20.2B
2015 Q3 923 234 M $21.5B
2015 Q2 943 236 M $23.2B
2015 Q1 940 234 M $23.6B
2014 Q4 919 236 M $22.4B
2014 Q3 876 233 M $22.5B
2014 Q2 849 237 M $22.0B
2014 Q1 833 238 M $20.8B